SciELO - Scientific Electronic Library Online

 
vol.17 issue2Ethical evaluation of pharmaceutical marketing in PakistanPharmacy industry research: conditioned by market interests? author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Acta bioethica

On-line version ISSN 1726-569X

Abstract

MARTIN, Carolina; WILLIAMS-JONES, Bryn  and  DE ORTUZAR, María Graciela. Ethical health technology assessment in Latin America: lessons from Canada and Argentina. Acta bioeth. [online]. 2011, vol.17, n.2, pp. 225-236. ISSN 1726-569X.  http://dx.doi.org/10.4067/S1726-569X2011000200009.

A wide array of biomedical and genetic technologies is becoming available in both developed and developing nations. This situation is the cause of growing concern for health policy makers who must evaluate the utility of these technologies for their inclusion in public health insurance programs. Ideally, policy makers would have the information necessary to rationally allocate scarce resources, prioritise technologies, and ensure fair access to necessary health care services. The reality, however, is that policy makers often do not have such information. In this paper, we argue that the field of Health Technology Assessment (HTA), through the integration of ethical analyses (i.e., an "ethical HTA"), can enable Argentinean and other Latin American policy makers to better understand the soco-ethical concerns raised by new biotechnologies.

Keywords : health technology assessment; bioethics; policy; genetics; prenatal tests; Argentina; Canada.

        · abstract in Spanish | Portuguese     · text in English     · pdf in English